Early Detection
424 articles
Searching for Potential Pancreatic Cancer Blood Biomarkers
Researchers are using blood samples to follow people considered at risk for developing pancreatic cancer in a trial looking for early detection biomarkers.
The Future of Pancreatic Cancer Treatment
Dr. Anil Rustgi discusses the latest developments in pancreatic cancer treatment and the direction of current research in early detection.
Decoding the Differences between At-Home and Medical Genetic Testing
Genetic counselors Jill Stopfer and Heather Hampel explain the differences between at-home and medical genetic testing, including precision and knowledge.
Meet the World Pancreatic Cancer Coalition
The World Pancreatic Cancer Coalition shows there is power when advocacy groups join together for the cause: World Pancreatic Cancer Day.
New Clues in Pancreatic Cancer Weight Loss
Dr. Matthew Vander Heiden is researching how pancreatic tumors trigger weight loss in pancreatic cancer patients, and the relationship with survival.
Pancreatic Cancer Research Builds Upon Strengths
The September 2023 AACR Special Conference on Pancreatic Cancer focused on the latest research in KRAS, chemotherapy, and cachexia, among other topics.
GENERATE Study Aims to Improve Genetic Testing and Prevention for Pancreatic Cancer
Dr. Sapna Syngal outlines the GENERATE study, which aims to help families with a risk for pancreatic cancer by providing genetic testing.
Research: The Next Generation
AACR young researchers come from all over the world, and add their perspectives to pancreatic cancer studies.
Tumor Genetics Research Brings Some Answers for Families at High Risk
Professor Gloria Peterson of the Mayo Clinic is working on tumor genetics to help make early detection of pancreatic cancer a reality.
What Is a Clinical Trial?
A clinical trial is a type of research study that tests new drugs or drug combinations, procedures, or medical devices in patients with specific diseases or conditions. The goal of a clinical trial is to determine if a potential new treatment is safe and effective. Treatments that are tested in clinical trials have already been […]
Kerri Kaplan
Kerri Kaplan is the President of the Lustgarten Foundation, which is America’s largest private funder of pancreatic cancer research and is relentlessly focused on improving patient outcomes. Kerri oversees all aspects of the Lustgarten Foundation’s operational activities, including major fundraising initiatives, patient outreach, and the Foundation’s in-depth research portfolio. Early in her career at the […]
AACR Virtual Special Conference on Pancreatic Cancer: Day One Highlights
Let’s Win and the Lustgarten Foundation present highlights of Day One of the AACR Virtual Special Conference on Pancreatic Cancer.
Pancreatic Cancer Science—2021 in Review
As the year winds down Let’s Win provides an overall look at the highlights of 2021 in pancreatic cancer science.
Pancreatic Cancer Organizations Join in Mourning Aretha Franklin
Let’s Win and the Elvin Howard, Sr. Pancreatic Cancer Advocacy Foundation join in mourning Aretha Franklin, and to raise awareness of pancreatic cancer.
ASCO Annual Conference: Highlights in Pancreatic Cancer Research
Dr. Allyson Ocean reviews some of the latest pancreatic cancer research results, including new treatments for some patients.